We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Abeona

News List

Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
December 25, 2019
The Company has granted to affiliates of GPP the right to nominate two Board members to Abeona's Board of Directors, including a new Executive Chairman, due to GPP's considerable investment in the transaction.
Abeona Therapeutics Appoints New SVP of Regulatory Affairs contractpharma
June 27, 2019
Victor Paulus named Senior Vice President, Regulatory Affairs and Jodie Gillon named Vice President of Patient Advocacy and Clinical Affairs.
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA biospace
April 25, 2018
Abeona Therapeutics Inc. announced today that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to ABO-102
Abeona Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Dise americanpharmaceuticalreview
March 19, 2018
Abeona Therapeutics announced the FDA has granted Rare Pediatric Disease Designation for the ABO-202 program an AAV-based gene therapy for the treatment of CLN1 disease